About Sunnybrook Research Institute - Odette Cancer Centre
Clinical Trials at Sunnybrook Research Institute - Odette Cancer Centre
During the past decade, Sunnybrook Research Institute - Odette Cancer Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sunnybrook Research Institute - Odette Cancer Centre"
#1 collaborator was "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials as a collaborator, "Exactis Innovation" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "Princess Margaret Hospital, Canada" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Sunnybrook Research Institute - Odette Cancer Centre
According to Clinical.Site data, the most researched conditions in "Sunnybrook Research Institute - Odette Cancer Centre" are
"Ovarian Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Glioblastoma Multiforme" (1 trials). Many other conditions were trialed in "Sunnybrook Research Institute - Odette Cancer Centre" in a lesser frequency.
Clinical Trials Intervention Types at Sunnybrook Research Institute - Odette Cancer Centre
Most popular intervention types in "Sunnybrook Research Institute - Odette Cancer Centre" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anastrozole" (1 trials), "Exemestane" (1 trials), "Imlunestrant" (1 trials), "Letrozole" (1 trials) and "Mirvetuximab soravtansine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sunnybrook Research Institute - Odette Cancer Centre
The vast majority of trials in "Sunnybrook Research Institute - Odette Cancer Centre" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Sunnybrook Research Institute - Odette Cancer Centre
Currently, there are NaN active trials in "Sunnybrook Research Institute - Odette Cancer Centre".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sunnybrook Research Institute - Odette Cancer Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sunnybrook Research Institute - Odette Cancer Centre, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".